TEXT 1

Tuberculosis
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs but can also impact other parts of the body such as the kidneys, spine, and brain. TB is a leading cause of death worldwide, particularly in developing countries. It spreads through the air when a person with active TB disease in their lung’s coughs, speaks, or sneezes, releasing droplets containing the bacteria.

Pathophysiology of Tuberculosis: TB infection begins when Mycobacterium tuberculosis bacteria are inhaled and reach the alveoli of the lungs. The body’s immune system responds by sending white blood cells to the lungs to engulf the bacteria. However, the bacteria can survive and multiply within these cells, leading to the formation of granulomas—clusters of immune cells that attempt to wall off the bacteria. In some cases, the bacteria remain dormant, resulting in latent TB infection. When the immune system cannot contain the bacteria, active TB disease develops, causing tissue damage and cavities in the lungs.

Clinical Manifestations: TB symptoms can vary depending on whether the disease is latent or active. Individuals with latent TB infection do not exhibit symptoms and are not contagious. Active TB disease symptoms include a persistent cough lasting three weeks or longer, chest pain, coughing up blood or sputum, unintentional weight loss, fever, night sweats, chills, fatigue, and loss of appetite. TB can also cause symptoms related to other organs if it spreads beyond the lungs.

Diagnosis: TB is diagnosed through a combination of clinical evaluation, imaging, and laboratory tests. The most common diagnostic tools include the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs) to detect latent TB infection. Active TB disease is confirmed with a chest X-ray or CT scan and microbiological testing, such as sputum smear microscopy and culture. Molecular tests like the Xpert MTB/RIF assay can quickly detect TB bacteria and resistance to rifampicin, an important TB drug.

Treatment and Management: TB treatment involves a combination of antibiotics taken for an extended period, usually six to nine months. The standard regimen for drug-susceptible TB includes isoniazid, rifampicin, ethambutol, and pyrazinamide for the first two months, followed by isoniazid and rifampicin for an additional four months. Drug-resistant TB requires longer and more complex treatment, often involving second-line drugs and possibly injectables. Adherence to the treatment regimen is critical to cure TB and prevent the development of drug-resistant strains.

Infection Control: Preventing TB transmission involves early detection and treatment of active TB cases, using airborne precautions such as wearing masks and ensuring good ventilation in healthcare settings. Latent TB infection treatment can reduce the risk of developing active TB disease. Vaccination with the Bacille Calmette-Guérin (BCG) vaccine provides some protection against severe forms of TB in children, though its efficacy in adults is limited.

Prognosis and Long-Term Outlook: With appropriate treatment, most people with TB can be cured. However, untreated TB can be fatal. Drug-resistant TB poses a significant challenge, as it requires longer and more complicated treatment with potentially severe side effects. Early diagnosis and adherence to treatment are crucial for improving outcomes and preventing the spread of TB.

Research and Future Directions: Ongoing research in TB focuses on developing shorter and more effective treatment regimens, new vaccines, and improved diagnostic tools. Advances in molecular biology and genomics are helping scientists understand TB bacteria better, paving the way for new therapeutic targets. Additionally, public health initiatives aim to improve TB control and reduce the global burden of the disease.

Conclusion: Tuberculosis remains a significant global health challenge that requires comprehensive strategies for early diagnosis, effective treatment, and prevention. With continued research and public health efforts, progress can be made towards eliminating TB and improving the lives of those affected by this disease.

Read the passage and answer the following questions.